PDS Biotechnology Corporation (PDSB) Financials
PDSB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 57.2 million | 32.7 million |
2023-06-30 | 63.8 million | 31.3 million |
2023-03-31 | 68.4 million | 27.4 million |
2022-12-31 | 77.0 million | 33.0 million |
PDSB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.2 million | 2.1 million |
2023-06-30 | -4.8 million | 2.1 million |
2023-03-31 | -13.2 million | 2.1 million |
2022-12-31 | -7.5 million | 1.4 million |
PDSB Net Income
No data available :(
PDSB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 54.3 million | - | 191938 |
2023-06-30 | 60.6 million | 23.3 million | 264464 |
2023-03-31 | 65.2 million | 23.1 million | 364380 |
2022-12-31 | 73.8 million | 23.0 million | 452054 |
PDSB Shares Outstanding
PDSB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 6.4 million | 4.1 million | - |
2023-06-30 | - | 8.0 million | 4.7 million | - |
2023-03-31 | - | 5.8 million | 3.6 million | - |
2022-12-31 | - | 16.2 million | 2.7 million | - |
PDSB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 14403 |
2023-06-30 | - | 74663 |
2023-03-31 | - | 74369 |
2022-12-31 | - | 11575 |
PDSB
Price: $3.82
52 week price:
Earnings Per Share: -1.39 USD
P/E Ratio: -3.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 392200
Market Capitalization: 140.1 million